Biomerica director buys 31,250 shares at $1.60
BIOMERICA INC (BMRA) director Gary M. Huff reported purchasing additional common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
BIOMERICA INC (BMRA) director Gary M. Huff reported purchasing additional common stock. On August 20, 2026, he acquired 31,250 shares of common stock at $1.60 per share, in a private placement by Biomerica pursuant to a Securities Purchase Agreement dated August 20, 2026. Following this transaction, he directly holds 51,250 shares of Biomerica common stock.
Insider Trade Summary
Net Buyer: 31,250 shares
Net Buy
1 txn
Insider
Gary M. Huff
Role
Director
Bought
31,250 shs ($50K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common stock F1 | 31,250 | $1.60 | $50K |
Holdings After Transaction:
Common stock — 51,250 shares (Direct)
Footnotes (1)
- F1. On August 26, 2026, the reporting person acquired 31,250 shares of the Issuer's common stock at a purchase price of $1.60 per share in private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated August 20, 2026, by and among certain institutional and individual investors identified on the signature pages thereto, which included among others B. Riley Principal Capital, LLC and certain members of the Company's Board of Directors and executive officers.
Key Figures
Shares purchased: 31,250 shares of common stock
Purchase price per share: $1.60 per share
Shares owned after transaction: 51,250 shares of common stock
+2 more
5 metrics
Shares purchased
31,250 shares of common stock
Acquired in transaction dated August 20, 2026, per Form 4
Purchase price per share
$1.60 per share
Private placement purchase price for 31,250 shares
Shares owned after transaction
51,250 shares of common stock
Direct holdings of Gary M. Huff following the reported purchase
Private placement acquisition date
August 26, 2026
Date footnote states shares were acquired in private placement
Securities Purchase Agreement date
August 20, 2026
Date of Securities Purchase Agreement governing the private placement
Key Terms
private placement, Securities Purchase Agreement, institutional and individual investors, B. Riley Principal Capital, LLC
4 terms
private placement financial
"acquired 31,250 shares ... in private placement by the Issuer"
A private placement is a sale of securities directly to a selected group of investors, typically institutions or accredited investors, instead of through a public offering. It lets a company raise money faster and with fewer regulatory steps; for existing shareholders it matters because the newly issued shares, often sold at a discount, increase the share count and can dilute their ownership.
Securities Purchase Agreement financial
"pursuant to the terms of a Securities Purchase Agreement dated August 20, 2026"
A securities purchase agreement is a written contract between a buyer and a seller outlining the terms for buying or selling financial assets such as stocks or bonds. It specifies details like the price, quantity, and conditions of the transaction, similar to a shopping list with agreed-upon terms. For investors, it provides clarity and legal protection when transferring ownership of these financial instruments.
institutional and individual investors financial
"by and among certain institutional and individual investors identified on the signature"
B. Riley Principal Capital, LLC financial
"which included among others B. Riley Principal Capital, LLC and certain members"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did BMRA director Gary M. Huff report?
Gary M. Huff reported a purchase of Biomerica common stock. He acquired 31,250 shares on August 20, 2026 at a price of $1.60 per share in a private placement conducted by Biomerica under a Securities Purchase Agreement.
Was the BMRA insider purchase by Gary M. Huff part of a 10b5-1 trading plan?
No. The Form 4 indicates the Rule 10b5-1 checkbox is not affirmed (aff_10b5_one is false), and the footnote describes the purchase as part of a private placement under a Securities Purchase Agreement, not as a trade under a 10b5-1 plan.
What is the context of the BMRA private placement involving Gary M. Huff?
The footnote states that on August 26, 2026, Gary M. Huff acquired 31,250 shares at $1.60 per share in a private placement by Biomerica under a Securities Purchase Agreement dated August 20, 2026, involving certain institutional and individual investors including B. Riley Principal Capital, LLC and some directors and executives.
AI-generated analysis. How Rhea-AI works. Not financial advice.
